What is Sartorius AG VZO O.N. (SRT.DE)?
Sartorius AG VZO O.N. trades as SRT.DE on the XETRA exchange (Germany) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-11-07.
Is SRT.DE in a Closelooknet index?
Yes — Sartorius AG VZO O.N. is a constituent of HALO Growth 100, as of 2026-11-07.
What is Sartorius AG VZO O.N.'s Closelooknet composite score?
45 out of 100, with momentum 87, quality 46 and valuation 29 sub-scores, as of 2026-11-07. Scores are Closelooknet's own research readings, not ratings or investment advice.
Where does SRT.DE trade against its moving averages?
Sartorius AG VZO O.N. trades 10.5% above its 50-day and 20.8% above its 200-day moving average (4.2% above its 20-day). As of 2026-11-05 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.
How is SRT.DE doing against its Closelooknet index?
Over the past month Sartorius AG VZO O.N. is +16.1% against +1.3% for the HALO Growth 100 — 14.8 points ahead of its index, as of 2026-11-06. Its Surgical, Med Devices & Animal Health sleeve is +13.6% over the same month. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.
How does Sartorius AG VZO O.N. compare with its peers?
Against its peer group (HALO Growth 100 · Surgical, Med Devices & Animal Health), Sartorius AG VZO O.N. (SRT.DE) sits 4.4% below its 52-week high, 10.5% above its 50-day average; DexCom Inc (DXCM) is 8.8% below, Globus Medical (GMED) is 19.7% below, IDEXX Laboratories Inc (IDXX) is 12.9% below, as of 2026-11-05. Put any of them next to SRT.DE in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.
What does Sartorius AG VZO O.N. do?
Sartorius makes bioprocess equipment and laboratory instruments used to develop and manufacture biological drugs, filters, cell-culture media, weighing systems and lab software. It serves life-science researchers, biopharmaceutical manufacturers and cell-and-gene therapy developers. It is based in Göttingen, Germany. Closelooknet's peer group places it with Intuitive Surgical, Stryker, DexCom, Insulet, IDEXX Laboratories, Globus Medical and Sonova, grouped as regulated compounders in surgery, devices and animal health; the market also compares it with Thermo Fisher Scientific. (Company snapshot of 2026-09-17.)
Where does Sartorius AG VZO O.N. sit in the AI build-out?
Sartorius is not part of our AI build-out index; it sits in the HALO Growth 100, our growth index outside the megacaps, within the sleeve for surgical, medical-device and animal-health names. That sleeve groups regulated equipment makers whose customers are hospitals, labs and biomanufacturers rather than chipmakers or data centres. It holds a seat in the HALO Growth 100 and carries a Closelooknet score, with momentum the strongest module and valuation the weakest; the diary has not yet quoted it in an edition. (Company snapshot of 2026-09-17.)
Does Sartorius AG VZO O.N. pay a dividend?
Sartorius AG VZO O.N. has paid 0.73 EUR per share over the last twelve months, paid once a year, a trailing yield of 0.32% on the 2026-11-06 close; the last distribution recorded in the price series was 0.73 EUR on 2026-03-27. In fiscal 2025 the company paid 51 m EUR in dividends, 24% of that year’s free cash flow. The share count rose 0.0% over the fiscal year. As of 2026-11-06; the "Dividends and capital return" block on this page carries the lines.
What does this page show?
A live price chart with SMA overlays and drawing tools for SRT.DE, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.